AnaptysBio Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
Forward P/E16.86
P/S Ratio4.4133.1885.6515.217.84
P/B Ratio5.686.463.362.691.48
Price/Tangible Book5.686.463.362.691.48
Enterprise Value Ratios
EV/Revenue3.7228.3173.849.623.34
Profitability & Returns
Return on Equity (ROE)-1.83%-0.93%-0.42%-0.15%-0.05%
Return on Assets (ROA)-0.15%-0.18%-0.11%-0.07%-0.04%
Return on Capital Employed (ROCE)-0.26%-0.38%-0.20%-0.09%-0.06%
Leverage & Solvency Ratios
Debt/Equity5.213.731.240.760.00
Liquidity Ratios
Current Ratio9.5110.8717.1634.4020.01
Quick Ratio9.3810.6216.9934.1019.86
Efficiency Ratios
Asset Turnover0.200.030.020.120.18
Yield & Distribution Ratios
Earnings Yield-0.36%-0.29%-0.15%-0.06%-0.03%
FCF Yield-0.34%-0.21%-0.08%-0.05%-0.03%
Buyback Yield-0.05%0.04%-0.03%0.00%-0.01%